Marketed in 55 countries across Europe, Latin America, Asia-Pacific, and North America, Voltaren is a globally distributed brand of diclofenac, classified within the nonsteroidal anti-inflammatory category. For travellers and expatriates, it is one of the most recognisable analgesic and antirheumatic brand names in international circulation, encountered in pharmacies on nearly every continent.
Voltaren is prescribed across a range of inflammatory and painful musculoskeletal conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, tenosynovitis, and backache. The structured indication block further down this page lists each registered use in the markets where Voltaren is sold. Diclofenac itself is associated with both systemic and topical formulations internationally, and country-by-country availability often reflects which formats a national regulator has approved.
Because the brand has such a wide footprint, the same product is often found under the Voltaren name across very different healthcare systems — examples include Brazil, Australia, Canada, China, and the Czech Republic — yet packaging, prescription status, and even which formulations are sold over the counter vary considerably. In some markets diclofenac is freely accessible as a topical product while requiring a prescription as an oral one; in others the rules are reversed. A local pharmacist is usually the fastest route to clarifying which Voltaren formats are available where you are.
Other molecules within the nonsteroidal anti-inflammatory class are also widely sold internationally under their own brand names, although they are not interchangeable without medical guidance. Anyone considering Voltaren, already taking it, or looking for a regional equivalent should treat that as a conversation with a qualified healthcare provider.
